Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease.

Internal medicine journal·2026
Same author

The Diversity of Transplant Glomerulitis and its Relationship to Alloantibody.

Kidney international reports·2026
Same author

BEAT-BK: An Adaptive, Randomized Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney-pancreas Transplantation Recipients (BEAT-BK) Study Protocol.

Transplantation direct·2026
Same author

Genetic Testing in Prospective Kidney Donors: Current Evidence and Clinical Practice in Australia.

Transplantation·2026
Same author

Enhanced Diagnosis of Chronic Antibody-mediated Rejection Using Peritubular Capillary Multilayering.

Transplantation·2025
Same author

Hmx2 and Dmrt2 Coordinate the Differentiation of Intercalated Cell Subtypes in Kidney.

Journal of the American Society of Nephrology : JASN·2025
Same journal

Atypical renal phenotype with tubular proteinuria and hypercalciuria in siblings with nail-patella syndrome: evidence for a dual genetic diagnosis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Blood pressure control in pediatric hemodialysis: data from the SCOPE collaborative.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Correlation between urinary soluble CD163 and endocapillary proliferation and fibrinoid necrosis in IgA vasculitis with nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

SGLT2i, anti-endothelin A and double endothelin and angiotensin inhibitors: a new future for chronic kidney disease in children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The role of urinary trehalase levels in the early diagnosis of acute kidney injury in dehydrated children.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Neuron-specific enolase and brain-derived neurotrophic factor as developmental neurovascular markers in chronic kidney disease and kidney transplantation.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Chronic allograft nephropathy.

Jeffery T Fletcher1, Brian J Nankivell, Stephen I Alexander

  • 1Department of Paediatrics, The University of Sydney, Nepean Clinical School, Nepean Hospital, Sydney, NSW, Australia.

Pediatric Nephrology (Berlin, Germany)
|June 28, 2008
PubMed
Summary
This summary is machine-generated.

Chronic allograft nephropathy (CAN) is a major cause of kidney transplant loss in children. Managing subclinical rejection and improving immunosuppression may reduce this, but risks must be considered.

More Related Videos

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

Related Experiment Videos

Last Updated: Jul 4, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pediatric Nephrology

Background:

  • Chronic allograft nephropathy (CAN) is the primary cause of graft loss in pediatric renal transplant recipients.
  • CAN results from combined immunological and non-immunological injuries, including rejection, ischemia, calcineurin toxicity, and infections.
  • The insidious onset of CAN can be preceded by subclinical rejection in seemingly well-functioning allografts.

Purpose of the Study:

  • To review the causes, histological classification, and current management challenges of chronic allograft nephropathy in pediatric kidney transplant recipients.
  • To discuss the potential role of protocol biopsy monitoring and newer immunosuppression strategies in mitigating CAN.
  • To highlight the balance between reducing immune injury and the risks of intensified immunosuppression and calcineurin inhibitor toxicity.

Main Methods:

  • Histological classification using the Banff criteria for renal allograft pathology.
  • Review of existing literature on causes of CAN in pediatric renal transplantation.
  • Analysis of current immunosuppression strategies and their impact on graft survival and complications.

Main Results:

  • Classic Banff findings for CAN include interstitial fibrosis, tubular atrophy, glomerulosclerosis, fibrointimal hyperplasia, and arteriolar hyalinosis.
  • Improved short-term graft survival due to better immunosuppression has not significantly reduced long-term chronic graft loss.
  • Opportunistic infections remain a significant complication in pediatric transplant recipients.

Conclusions:

  • While improved immunosuppression enhances 1-year survival, chronic graft loss persists, and infections are problematic.
  • Protocol biopsies are not standard for CAN monitoring but may be valuable if new treatments emerge.
  • Future strategies focusing on closer monitoring and managing subclinical rejection could reduce CAN, but require careful risk-benefit assessment regarding immunosuppression toxicity.